Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 1;6(8):e2327319.
doi: 10.1001/jamanetworkopen.2023.27319.

Injection Drug Use Frequency Before and After Take-Home Naloxone Training

Samantha Colledge-Frisby  1   2   3 , Kasun Rathnayake  2 , Suzanne Nielsen  2   4 , Mark Stoove  2 , Lisa Maher  5 , Paul A Agius  2   6 , Peter Higgs  2   7 , Paul Dietze  1   2
Affiliations

Injection Drug Use Frequency Before and After Take-Home Naloxone Training

Samantha Colledge-Frisby et al. JAMA Netw Open. .

Abstract

Importance: Concerns that take-home naloxone (THN) training may lead to riskier drug use (as a form of overdose risk compensation) remain a substantial barrier to training implementation. However, there was limited good-quality evidence in a systematic review of the association between THN access and subsequent risk compensation behaviors.

Objective: To assess whether THN training is associated with changes in overdose risk behaviors, indexed through injecting frequency, in a cohort of people who inject drugs.

Design, setting, and participants: This cohort study used prospectively collected self-reported behavioral data before and after THN training of participants in The Melbourne Injecting Drug User Cohort Study (SuperMIX). Annual interviews were conducted in and around Melbourne, Victoria, Australia, from 2008 to 2021. SuperMIX participants were adults who regularly injected heroin or methamphetamine in the 6 months preceding their baseline interview. The current study included only people who inject drugs who reported THN training and had participated in at least 1 interview before THN training.

Exposure: In 2017, the SuperMIX baseline or follow-up survey began asking participants if and when they had received THN training. The first THN training date that was recorded was included as the exposure variable. Subsequent participant interviews were excluded from analysis.

Main outcomes and measures: Injecting frequency was the primary outcome and was used as an indicator of overdose risk. Secondary outcomes were opioid injecting frequency, benzodiazepine use frequency, and the proportion of the time drugs were used alone. Fixed-effects generalized linear (Poisson) multilevel modeling was used to estimate the association between THN training and the primary and secondary outcomes. Time-varying covariates included housing status, income, time in study, recent opioid overdose, recent drug treatment, and needle and syringe coverage. Findings were expressed as incidence rate ratios (IRRs) with 95% CIs.

Results: There were 1328 participants (mean [SD] age, 32.4 [9.0] years; 893 men [67.2%]) who completed a baseline interview in the SuperMIX cohort, and 965 participants completed either a baseline or follow-up interview in or after 2017. Of these 965 participants, 390 (40.4%) reported THN training. A total of 189 people who inject drugs had pretraining participant interviews with data on injecting frequency and were included in the final analysis (mean [SD] number of interviews over the study period, 6.2 [2.2]). In fixed-effects regression analyses adjusted for covariates, there was no change in the frequency of injecting (IRR, 0.91; 95% CI, 0.69-1.20; P = .51), opioid injecting (IRR, 0.95; 95% CI, 0.74-1.23; P = .71), benzodiazepine use (IRR, 0.96; 95% CI, 0.69-1.33; P = .80), or the proportion of reported time of using drugs alone (IRR, 1.04; 95% CI, 0.86-1.26; P = .67) before and after THN training.

Conclusions and relevance: This cohort study of people who inject drugs found no evidence of an increase in injecting frequency, along with other markers of overdose risk, after THN training and supply. The findings suggest that THN training should not be withheld because of concerns about risk compensation and that advocacy for availability and uptake of THN is required to address unprecedented opioid-associated mortality.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Nielsen reported receiving a Career Development Fellowship grant from National Health and Medical Research Council (NHMRC) and grants from Seqirus unrelated to study prescription opioid poisoning funding, and being named on a buprenorphine depot trial by Indivior outside the submitted work. Dr Higgs reported receiving investigator-initiated research funding from Gilead Sciences, Abbvie, NHMRC, and Australian Research Council outside the submitted work. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Flowchart of Participant Inclusion
SuperMIX is The Melbourne Injecting Drug User Cohort Study. THN indicates take-home naloxone.
Figure 2.
Figure 2.. First-Reported Take-Home Naloxone Training Year
See this image and copyright information in PMC

References

    1. Strang J, Darke S, Hall W, Farrell M, Ali R. Heroin overdose: the case for take-home naloxone. BMJ. 1996;312(7044):1435-1436. doi:10.1136/bmj.312.7044.1435 - DOI - PMC - PubMed
    1. Olsen A, Dwyer R, Lenton S. Take-home naloxone in Australia and beyond. Drug Alcohol Rev. 2018;37(4):437-439. doi:10.1111/dar.12700 - DOI - PubMed
    1. Naumann RB, Durrance CP, Ranapurwala SI, et al. . Impact of a community-based naloxone distribution program on opioid overdose death rates. Drug Alcohol Depend. 2019;204:107536. doi:10.1016/j.drugalcdep.2019.06.038 - DOI - PMC - PubMed
    1. Tse WC, Djordjevic F, Borja V, et al. . Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a ‘moral hazard’ associated with naloxone supply. Int J Drug Policy. 2022;100:103513. doi:10.1016/j.drugpo.2021.103513 - DOI - PubMed
    1. Winograd RP, Davis CS, Niculete M, Oliva E, Martielli RP. Medical providers’ knowledge and concerns about opioid overdose education and take-home naloxone rescue kits within Veterans Affairs health care medical treatment settings. Subst Abus. 2017;38(2):135-140. doi:10.1080/08897077.2017.1303424 - DOI - PubMed

Publication types